| Reactivity | Human |
| Detection Range | 0.16-10ng/mL |
| Sensitivity | 0.1ng/mL |
This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Human BPn. During the reaction, Human BPn in the sample or standard
competes with a fixed amount of Human BPn on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Human BPn. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometric ally at a wavelength of 450 nm. The concentration of Human BPn in tested samples can be calculated by comparing the OD of the samples to the standard curve.
| Catalog Number | LAB10589 |
| Reactivity | Human |
| Detection Range | 0.16-10ng/mL |
| Sensitivity | 0.1ng/mL |
Product name: | Lablisa® Human BPn (biopyrrin) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | biopyrrin |
| Assay Type: | Competitive |
| Sensitivity: | 0.1ng/mL |
| Standard: | 10ng/mL |
| Range: | 0.16-10ng/mL |
| Sample Type: | Serum, Plasma and Tissue homogenate and other biological samples;Sample volume:25μL |
| Assay Length: | 1.5H |
| Research Area: | Signal transduction;Metabolic pathway;Endocrinology;Cardiovascular biology;Neuro science;Hormone metabolism;Bone metabolism; |
Standard curve
| Concentration (pg/mL) | OD |
|---|---|
| 10 | 0.205 |
| 5 | 0.382 |
| 2.5 | 0.65 |
| 1.25 | 0.984 |
| 0.63 | 1.281 |
| 0.31 | 1.494 |
| 0.16 | 1.87 |
| 0 | 2.757 |
Precision
Intra-assay Precision (Precision within an assay) :CV%<8% Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays) :CV%<10% Three samples of known concentration were tested in forty separate assays to assess inter-assay
precision.
Recovery
Matrices listed below were spiked with certain level of recombinant Human BPn and the recovery rates were calculated by comparing the measured value to the expected amount of Human BPn in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=8) | 97-104% | 100% |
| EDTA plasma(n=8) | 87-97% | 92% |
| Cell culture media (n=8) | 89-97% | 92% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Human BPn and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=8) | 91-99% | 88-97% | 89-98% | 95-101% |
| EDTA plasma(n=8) | 92-100% | 98-106% | 89-97% | 98-106% |
| Cell culture media (n=8) | 92-101% | 91-98% | 95-101% | 88-96% |
Manuals on the web are for your reference only, specifications are subject to the delivery manuals.
Available Soon...
Share your experience with this product to help other researchers.
Login to Submit a ReviewNo reviews yet. Be the first to share your experience!